Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases

BACKGROUND: To evaluate the antitumor activity and toxicity of icotinib as initial treatment in lung adenocarcinoma patients with brain metastases. METHODS: Twenty‐one patients with histologically or pathologically documented brain metastatic lung cancer were administered icotinib as initial treatme...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Thorac Cancer
Egile Nagusiak: Xu, Jian‐ping, Liu, Xiao‐yan, Yang, Sheng, Zhang, Chang‐gong, Wang, Lin, Shi, Yuan‐kai
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons Australia, Ltd 2016
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4930963/
https://ncbi.nlm.nih.gov/pubmed/27385986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12351
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak